Hydroxyethyl Starch

Hydroxyethyl Starch is a starch that is composed of more than 90 % of amylopectin. Hydroxyethyl Starch is a plasma volume expander. Hydroxyethyl Starch is used in the management of hypovolemic shock.

Hydroxyethyl Starch is primarily indicated in conditions like Burns, Hypovolaemia, Infections, Low blood volume, Shock, Trauma.

Hydroxyethyl Starch is contraindicated in conditions like Renal failure, Haemorrhage, Anuria, Oliguria, Coagulation disorder.

The severe or irreversible adverse effects of Hydroxyethyl Starch, which give rise to further complications include Increased serum amylase. Hydroxyethyl Starch produces potentially life-threatening effects which include Anaphylaxis. which are responsible for the discontinuation of Hydroxyethyl Starch therapy. The symptomatic adverse reactions produced by Hydroxyethyl Starch are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Tachycardia, Itching, Fall in BP.

Caution should be observed before administering Hydroxyethyl Starch to patients with severe liver disease or severe bleeding disorders. In cases of severe dehydration, a crystalloid solution should be given first. Generally, sufficient fluid should be administered in order to avoid dehydration.

Drug should not be given to Pregnant Mothers, Cardiac / Hypertensive Patients, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

33 to 66 ml/ kg (50 (49.5)) As recommended. IV Inf — As Required 50 to 1000 ml (520 (525)) As recommended. IV-inf — As required.

Safety and efficacy have not been established. ( ) —

No neonatal dosage information is recorded for this medicine yet.

No data regarding the interactions of Hydroxyethyl Starch was found.

No storage information is recorded for this medicine yet.